Generated July 2026 from current fund data.
Overview
GPIQ and ROCQ are both monthly-income ETFs built on the Nasdaq-100, using covered-call overlays to generate yield beyond what the underlying index alone would produce. Both arrived within the past two years as the covered-call ETF category exploded. The key distinction: GPIQ is a $4.62B fund from Goldman Sachs with a 10.90% distribution rate and explicit beta tracking near 1.1, while ROCQ is a much smaller JPMorgan offering ($316M) launched more recently with a 11.27% yield and reported beta of zero.
How they differ
GPIQ and ROCQ pursue the same core playbook—holding Nasdaq-100 stocks and selling calls against them—but size, maturity, and reported market sensitivity diverge sharply. GPIQ has nearly 15 times the assets, a longer track record (since October 2023 versus March 2026), and a beta around 1.1, meaning it moves roughly in line with its underlying index; ROCQ's beta is reported at 0.0, a structural claim that suggests call sales are suppressing price moves more aggressively or that the fund's correlation to the Nasdaq-100 is functionally flat. ROCQ's distribution rate edges higher at 11.27% versus GPIQ's 10.90%, but ROCQ carries a marginally higher expense ratio (0.35% versus 0.29%) and is substantially smaller, raising liquidity and capacity questions. GPIQ's larger AUM and longer operating history provide more price discovery and evidence of how the covered-call strategy performs across market cycles.
Who each is best for
GPIQ: Fits investors drawn to Nasdaq-100 exposure who want monthly income supplemented by call premiums, and who accept near-market-rate volatility in exchange for a lower fee and an established track record in the covered-call space.
ROCQ: Fits investors prioritizing yield and a claimed reduction in equity-like drawdowns, and who are comfortable with a newer, smaller fund and the concentration risk that can accompany tighter option-overlay execution.
Key risks to know
- NAV erosion at elevated yields. Both funds distribute 10.9% to 11.3% annually against a $55–$57 price point; if underlying equity returns fall short of that payout, NAV will gradually decline. This is structural to high-yield covered-call funds and not unique to these two, but the magnitude matters: sustained underperformance of the Nasdaq-100 would force a choice between cutting distributions or accelerating principal decay.
- Call-cap constraint and opportunity loss. Covered calls cap upside. If the Nasdaq-100 rallies sharply, both funds' long positions will be called away at predetermined strikes, locking in gains but ceding further appreciation to shareholders. The tighter the call strikes (more aggressive premium capture), the sooner this constraint bites.
- Liquidity mismatch and tracking risk in ROCQ. At $316M in AUM, ROCQ is one-fifteenth the size of GPIQ and recently launched, raising the risk that option-overlay precision degrades during market stress or periods of heavy redemptions. GPIQ's scale offers more cushion for consistent execution and tighter NAV tracking to its stated strategy.
- Beta reporting credibility in ROCQ. A reported beta of 0.0 for an equity fund holding Nasdaq-100 stocks is highly unusual and warrants skepticism; it suggests either measurement error, a very short sample period, or an overlay so tight that equity exposure is nearly eliminated—none of which is transparently explained in the fund's materials.
Bottom line
GPIQ offers established scale, transparent market-rate sensitivity, and a lower fee; ROCQ pitches a higher yield and claimed downside protection via a zero-beta claim. If you value liquidity, track record, and clarity on what you're holding, GPIQ's maturity advantage stands out; if you prioritize maximum current income and can tolerate a newer, smaller fund, ROCQ's yield edge may appeal. Past performance, especially over the short two-year window these funds have operated, does not predict future results.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.